All Stories

  1. Inflammation in Atrial Fibrillation–Related Stroke

    Article • Neurology, March 2026, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  2. Anti-Ro/SSA-antibody testing for isolated atrioventricular block in adults: a diagnostic and therapeutic work-up

    Article • European Heart Journal, March 2026, Oxford University Press (OUP)

    MD Pietro Enea Lazzerini

  3. Kinase-driven inflammasome resolution: shifting the paradigm for atherosclerosis management

    Article • European Heart Journal, February 2026, Oxford University Press (OUP)

    MD Pietro Enea Lazzerini

  4. Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients

    Article • Antioxidants, March 2025, MDPI AG

    MD Pietro Enea Lazzerini

  5. Pro-arrhythmic potential of proton-pump inhibitors

    Article • Nature Reviews Cardiology, December 2024, Springer Science + Business Media

    MD Pietro Enea Lazzerini

  6. Increased interleukin‐6 levels are associated with atrioventricular conduction delay in severe COVID‐19 patients

    Article • Journal of Arrhythmia, July 2024, Wiley

    MD Pietro Enea Lazzerini

  7. The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study

    Article • Journal of Clinical Medicine, July 2024, MDPI AG

    MD Pietro Enea Lazzerini

  8. Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti‐Ro/Sjögren Syndrome–Related Antigen A Antibodies

    Article • Journal of the American Heart Association, June 2024, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  9. Elevated Interleukin‐6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans

    Article • Journal of the American Heart Association, February 2024, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  10. Contribution of cytokine-mediated prolongation of QTc interval to the multi-hit theory of Torsade de Pointes

    Article • Biochemical and Biophysical Research Communications, May 2023, Elsevier

    MD Pietro Enea Lazzerini

  11. Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the ‘dark side of the immune’

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    MD Pietro Enea Lazzerini

  12. Anti-Ca v 1.2 Antibody–Induced Atrioventricular Block as a Novel Form in the Adult: Long-Term Pacemaker-Sparing Activity of Hydroxychloroquine

    Article • Circulation Arrhythmia and Electrophysiology, July 2022, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  13. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19

    Article • Nature Reviews Immunology, March 2022, Springer Science + Business Media

    MD Pietro Enea Lazzerini

  14. Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men

    Article • Journal of the American Heart Association, January 2022, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  15. Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine‐Mediated Inhibition of Connexin43 Expression

    Article • Journal of the American Heart Association, November 2021, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  16. Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans

    Article • Circulation Arrhythmia and Electrophysiology, July 2021, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  17. Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study

    Article • Journal of the American Heart Association, February 2021, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  18. Letter by Acampa et al Regarding Article, “Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine”

    Article • Stroke, February 2021, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  19. IL-6 (Interleukin 6) Blockade and Heart Rate Corrected QT Interval Prolongation in COVID-19

    Article • Circulation Arrhythmia and Electrophysiology, September 2020, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  20. Cardiac Arrest Risk During Acute Infections

    Article • Circulation Arrhythmia and Electrophysiology, August 2020, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  21. COVID-19, Arrhythmic Risk, and Inflammation

    Article • Circulation, July 2020, Wolters Kluwer Health

    MD Pietro Enea Lazzerini

  22. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies

    Article • Nature Reviews Immunology, December 2018, Springer Science + Business Media

    MD Pietro Enea Lazzerini

  23. Torsades de Pointes in Patients with Polymyalgia Rheumatica

    Article • Current Pharmaceutical Design, April 2018, Bentham Science Publishers

    MD Pietro Enea Lazzerini

  24. Previous use of Statins and Atrial Electrical Remodeling in Patients with Cryptogenic Stroke

    Article • Cardiovascular & Haematological Disorders - Drug Targets, February 2018, Bentham Science Publishers

    MD Pietro Enea Lazzerini, Dr Maurizio Acampa, Rossana Tassi

  25. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date

    Article • Drug Design Development and Therapy, September 2016, Dove Medical Press

    MD Pietro Enea Lazzerini, Dr Maurizio Acampa

  26. Inflammation and arrhythmic risk in rheumatoid arthritis

    Article • European Heart Journal, June 2016, European Society of Cardiology

    MD Pietro Enea Lazzerini

  27. Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation

    Article • Arthritis Care & Research, February 2015, Wiley

    MD Pietro Enea Lazzerini, Dr Maurizio Acampa

  28. The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF‐α

    Article • European Journal of Immunology, October 2013, Wiley

    Luca Cantarini, MD Pietro Enea Lazzerini